Physician profile
Danielle Martter
NPI 1336359645
$752.56
in general payments reported to CMS, 2019-2025
15 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.60 · 2021: $63.46 · 2022: $335 · 2023: $130 · 2024: $62.42 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.94 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $170.20 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $107.48 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $82.40 | 2022 | |
| Exeltis, USA INC. | $77.37 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $67.57 | 2022-2024 | Myosure Tissue Removal Device |
| Mayne Pharma Commercial LLC | $64.70 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.28 | 2022 | |
| Agile Therapeutics, INC. | $26.46 | 2022 | |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Myovant Sciences INC. | $18.43 | 2022 | |
| Optumhealth Care Solutions, LLC | $16.82 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Pfizer INC. | $12.84 | 2021 | |
| Therapeuticsmd, INC. | $12.75 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.26 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Martter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.